The Parker Institute

What The Parker Institute does

The Parker Institute is a non-profit clinical research institute operating as an integrated department within Copenhagen University Hospital at Bispebjerg and Frederiksberg in Frederiksberg, Denmark. Founded in 1999, it focuses on rheumatology and musculoskeletal disease research spanning osteoarthritis, rheumatoid arthritis, soft tissue pain conditions, and the sequelae of torture. Activities include register-based research, patient-reported outcome diagnostics, randomized clinical trials, biomechanical evaluation, and imaging via in-house ultrasound and hospital-shared MRI.

The Institute is organized into seven research units covering physiotherapy and biomechanics, occupation-centred occupational therapy, dietary studies, clinical research, biostatistics and evidence-based research, imaging, and biochemistry/physiology. It has developed proprietary research platforms and devices including the DoloCuff computerized cuff pressure system for pain assessment, the Trace™ home blood-testing device for biologic medicine monitoring, the ELECTOR eHealth platform for home-based arthritis monitoring, and contributions to the NoHoW Horizon2020 weight-loss maintenance project. Research output has appeared in The Lancet, BMJ, and JAMA Internal Medicine.

The Institute does not sell commercial products; its operations are funded through grants. A generous core grant from the Oak Foundation underwrites basic operations and an annual international scientific advisory board review, while additional funding comes from Innovation Fund Denmark, Independent Research Fund Denmark, Trygfonden, EU Horizon2020 programs, and industry-sponsored multicenter trials such as the Novo Nordisk amycretin obesity-osteoarthritis study. Apart from the director, who is employed by Capital Region H of Denmark, all staff are grant-funded.

Name

The Parker Institute

Legal name

The Parker Institute

Website

https://parkerinst.dk

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

51–100 employees

Short description

The Parker Institute is a Danish non-profit clinical research institute within Copenhagen University Hospital at Bispebjerg and Frederiksberg, conducting multidisciplinary research on musculoskeletal and rheumatological diseases through randomized trials, imaging, biomechanics, and eHealth platforms, funded primarily by the Oak Foundation and public grants.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Chronic Pain Rehabilitation & Functional Restoration (HSADAIAJ)

akta.pro secondary industries

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG), Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ)

Keywords

• Rheumatology research
• Musculoskeletal research
• Clinical trials
• Biomechanical evaluation
• Medical research institute

Headquarters

HQ city

Frederiksberg

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Grant Funding: Staff employed on basis of grants from public and private foundations. Apart from the director employed by the Capital Region H of Denmark, all staff is grant-funded.
2. Basic Funding (Oak Foundation): Generous basic grant from the Oak Foundation supporting core operations. Research is subjected to yearly evaluation by international scientific advisory board established by The Oak Foundation.
3. Clinical Trial Participation: Participates in industry-sponsored projects and investigator-initiated research collaborations

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

The Parker Institute conducts clinical and translational research on musculoskeletal and rheumatological diseases, including osteoarthritis, rheumatoid arthritis, soft tissue pain conditions, and sequels of torture. It delivers evidence-based prevention, diagnostics, and treatment strategies through observational, register-based, and randomized clinical studies, supported by imaging (ultrasound and MRI), biomechanical evaluation, biochemical analyses, and specialized medical devices such as the DoloCuff pain assessment tool and Trace™ home blood-testing device.

Product overview

The Parker Institute conducts clinical research in musculoskeletal diseases, operating primarily as a research institution rather than a product company. Its research platforms include ELECTOR (eHealth monitoring platform for arthritis patients) and NoHoW (weight loss maintenance research). Key medical technologies developed include DoloCuff (computerized pain assessment device) and Trace™ (home blood-testing device for biologic medicine monitoring). The institute also performs biomechanical evaluation, imaging diagnostics (ultrasound and MRI), and biochemical analyses as part of its research activities.

Differentiator

Problem solved

Functional benefit

Products and services

• ELECTOR eHealth Platform An eHealth platform developed for home-based monitoring of patients with arthritis, combining point-of-care devices for measuring biochemistry at home with a web-based graphical user interface for communication, knowledge transfer, questionnaire reporting, and joint assessments. Targeted at patients with chronic rheumatic diseases and the clinicians managing their care.
• NoHoW Research Project A European research project funded by the EU Horizon2020 programme focused on weight loss maintenance in obese patients, investigating strategies and digital tools to help patients sustain weight loss.
• DoloCuff A computerized cuff pressure equipment developed by The Parker Institute for pain assessment. It has been tested and validated in various patient groups and is used for systematic follow-up on sensitivity to pain at both individual and group levels.
• Trace™ Home Blood-Testing Device A small blood-testing device for home use that enables patients to retrieve information about the level of medicine and possibly neutralising antibodies within 15 minutes from home, supporting personalised medicine for patients receiving biologic medicine.
• Clinical Research Services in Musculoskeletal Diseases Conduct of investigator-initiated and industry-sponsored clinical studies in degenerative musculoskeletal diseases (e.g., osteoarthritis), immuno-inflammatory joint diseases (e.g., rheumatoid arthritis), soft tissue pain conditions, and sequels of torture, using patient-reported outcomes, clinical examination, imaging diagnostics, laboratory measurements, biomechanics, and functional tests.

Quantifiable outcome

• Research publications in high-impact journals including The Lancet, BMJ, JAMA Internal Medicine
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered major and core.

• Novo NordiskmajorStrategic or Co-development Partner · 26 January 2026The Parker Institute is participating in a multicenter trial testing amycretin, a new weight loss medication for obese persons with knee osteoarthritis. The one-year trial will randomize participants 2:1 (medication:placebo) with dietary advice provided to all participants.
• Bispebjerg & Frederiksberg Hospital - Department of RheumatologycoreStrategic or Co-development PartnerMuch of the clinical research is carried out in collaboration with the outpatient clinic of the Department of Rheumatology. The Bispebjerg & Frederiksberg Hospital sponsors musculoskeletal imaging research and has obtained MRI scanners from sponsors.
• NoHoW Project (EU Horizon2020)majorStrategic or Co-development PartnerEU-funded research project on weight loss maintenance. The Parker Institute participates in this international collaborative research initiative.
• ELECTOR Project (EU)majorStrategic or Co-development PartnereHealth platform development project for home-based monitoring of patients with arthritis. Adaptive and flexible solution for monitoring chronic diseases.
• Cochrane CollaborationmajorStrategic or Co-development PartnerThe Musculoskeletal Statistics Unit at The Parker Institute is part of a global network of researchers from the Cochrane Collaboration, conducting systematic reviews and meta-analyses.
• Cochrane Musculoskeletal Satellite Group DenmarkmajorStrategic or Co-development PartnerCochrane Musculoskeletal has established a Satellite Group in Denmark hosted at The Parker Institute, supporting evidence synthesis in rheumatology.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Regional players

• Versus Arthritis: UK-based charitable funder and research commissioner for MSK disease research, supporting multiple academic centers. Comparable as a stakeholder in the European MSK research ecosystem, though operating as a funder rather than an in-house research institute.
• Lund University - Department of Clinical Sciences, Rheumatology: Swedish university with active rheumatology research including epidemiology and clinical trials in MSK diseases. Comparable as a Nordic regional peer conducting hospital-integrated rheumatology research.

Direct peers

• Karolinska Institutet: Sweden's leading medical research university with a major rheumatology unit and clinical trial infrastructure comparable to The Parker Institute. Both are Northern European academic research centers focused on MSK and rheumatology with embedded hospital collaborations.
• Nordic Bioscience: Denmark-based clinical research and biomarker company focused on musculoskeletal and connective tissue diseases. Comparable through its Danish base, MSK research focus, and development of diagnostic and prognostic biomarkers for rheumatic disease.
• Diakonhjemmet Hospital: Norwegian hospital hosting a prominent rheumatology research division (REMEDY) conducting clinical trials and evidence synthesis in MSK diseases. Operates a similar model of hospital-integrated rheumatology research in the Nordic region.

Broad incumbents

• Brigham and Women's Hospital - Division of Rheumatology: Harvard-affiliated US hospital with a top-ranked rheumatology division conducting large-scale clinical trials and translational research in arthritis and MSK diseases. Comparable for evidence-based clinical research and high-impact publication output.
• Leiden University Medical Center - Department of Rheumatology: Major Dutch academic medical center with one of Europe's largest rheumatology research divisions. Comparable for clinical trial activity in rheumatoid arthritis and MSK disease, with broader scope and larger headcount than The Parker Institute.
• Mayo Clinic - Division of Rheumatology: US integrated clinical practice with a leading rheumatology research program. Comparable for high-impact publications, clinical trial infrastructure, and proprietary diagnostic/biomarker development in rheumatic diseases.
• Erasmus MC - Department of Rheumatology: Large Dutch university medical center with a substantial rheumatology research portfolio, including clinical trials and imaging-based diagnostics. Operates as a broader incumbent compared to The Parker Institute's focused MSK remit.

Others

• Cochrane Musculoskeletal: Global evidence-synthesis network for MSK diseases of which The Parker Institute hosts the Danish satellite group. Directly comparable for systematic review methodology and meta-analysis in rheumatology research.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/ParkerInstituttetsPatientforening
• LinkedInlinkedin.com/company/the-parker-institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Parker Institute